Global landscape of clinical trials and therapeutic targets in metabolic dysfunction-associated steatotic liver disease: an integrative multi-omics analysis.
- DOI
- 10.1007/s40618-026-02991-4
- Published
- 2026 Aug 26
- Container
- Journal of endocrinological investigation
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40618-026-02991-4,
title = {Global landscape of clinical trials and therapeutic targets in metabolic dysfunction-associated steatotic liver disease: an integrative multi-omics analysis.},
author = {Mu Y and Zhu W and Wei Z and Guo Z and Chen H and Cheng Y and Zhou W},
year = {2026},
journal = {Journal of endocrinological investigation},
doi = {10.1007/s40618-026-02991-4},
url = {https://doi.org/10.1007/s40618-026-02991-4}
}RIS
TY - JOUR TI - Global landscape of clinical trials and therapeutic targets in metabolic dysfunction-associated steatotic liver disease: an integrative multi-omics analysis. AU - Mu Y AU - Zhu W AU - Wei Z AU - Guo Z AU - Chen H AU - Cheng Y AU - Zhou W PY - 2026 JO - Journal of endocrinological investigation DO - 10.1007/s40618-026-02991-4 UR - https://doi.org/10.1007/s40618-026-02991-4 ER -
APA
Y, M., W, Z., Z, W., Z, G., H, C., Y, C., & W, Z. (2026). Global landscape of clinical trials and therapeutic targets in metabolic dysfunction-associated steatotic liver disease: an integrative multi-omics analysis.. Journal of endocrinological investigation. https://doi.org/10.1007/s40618-026-02991-4
Source records
- pubmed · retrieved 2026-09-25T14:59:46.655Z
- europe-pmc · retrieved 2026-09-25T14:59:46.664Z